Resources
State of AMR Report 2024
Research from the world’s leading health authorities on the status of antimicrobial resistance. Get the facts and join the fight.
CARB-X
We are working with the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria.
InnovateUK
We have an aligned mission with InnovateUK when it comes to AMR. InnovateUK supports GenomeKey with funding and business support to see our product come to market and save lives.
NHS Trusts
We work closely with the NHS to ensure our technology is designed with the end users needs in mind. Through our NHS partners we are able to trial and evaluate our technology.
NVIDIA
The NVIDIA Inception program supports GenomeKey development through access to cutting-edge technology and NVIDIA experts, opportunities to connect with venture capitalists, and co-marketing support.
SetSquared Bristol
SetSquared Bristol is a business incubator and support program that supports GenomeKey to grow and succeed. They provide a range of resources and services to help develop our Business and network with other Entrepreneurs.
West of England Academic Health Science Network
Part of a network of organisations that aims to improve healthcare and support innovation in the healthcare sector by providing access to expertise and healthcare institutions.
Our approach
Led by purpose
We believe novel technologies like machine learning, molecular biology, and whole genome sequencing will trigger a step-change in healthcare. Sepsis and AMR are universal threats which require a universal solution.
Partnering for greater impact
GenomeKey believes nobody should die of a treatable infection, and we mean nobody globally. To achieve this we need global partners. We are the only company in the world with a viable, low-cost and accessible solution which can be used worldwide to tackle the number one cause of death.
Become a GenomeKey partner today
Investors
Register your interest as an investor and we will contact you when we are next raising funding.
R&D Partners
Work with us to deliver a more robust, reliable and comprehensive diagnostic device to tackle the leading cause of death.
Clinical Partners
We always welcome clinical partnerships to support our journey and test our technology. We would love to hear from you.
Resources
Resources
Insights
Sepsis: a deadly symptom of social inequality?
New UK Study links poverty with sepsis Between January 2019 and June 2022, the University of Manchester analysed 248,767 cases of non-Covid sepsis in England. Funded by HDR UK, the UK Health Security Agency, and...
Insights
Cutting the human and financial costs of sepsis with precision diagnostics
In recent history, many of us have grown used to our healthcare improving. Thanks to new knowledge and medical technologies we now live longer, and we routinely treat many conditions that posed serious threats to...
Research
Giving clinicians the tools to tackle sepsis
We are living through a period of profound technological change. Machine learning and AI could transform many aspects of our lives, which explains why governments and tech companies are so focused on these fields. Some...
